Generic Name and Formulations:
Nepafenac 0.1%, oph. susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for NEVANAC:
Post-operative pain and inflammation following cataract surgery.
≥10yrs: 1 drop in affected eye(s) 3 times daily starting one day before surgery, continued on day of surgery, and through first 2 weeks post-op.
<10yrs: not established.
Bleeding tendencies. May delay wound healing. Complicated/repeat ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used more than 24 hours before surgery, or beyond 14 days post-op. Contact lenses (remove during therapy). Pregnancy (Cat.C; avoid during 3rd trimester). Nursing mothers.
Caution with concomitant medications that may prolong bleeding time. Increased potential for healing problems with concomitant topical steroids.
Ocular effects (eg, capsular opacity, decreased visual acuity, foreign body sensation, increased intraocular pressure, sticky sensation, edema, dry eye, lid margin crusting, discomfort, hyperemia, pain, pruritus, photophobia, tearing, vitreous detachment), headache, hypertension, GI upset, sinusitis.